期刊文献+

狼疮性肾炎抗活化蛋白C的测定及意义

The detection of activated protein Cand in lupus nephritis its significance
下载PDF
导出
摘要 目的 :探讨抗磷脂抗体和抗活化蛋白C(APCR)与狼疮性肾炎 (LN)的关系及APCR的可能形成原因。方法 :检测 33例LN和 37例无LN的系统性红班狼疮 (NLN) ,ELISA检测ACA -IgG、IgM、IgA、PTT -LA检测LA ,APTT±APC检测APCR。结果 :LN组APCR阳性率 5 7 6% ,明显高于NLN组 ( 32 4% ) ;LN组ACA(IgG、IgM )阳性率 42 4% ,明显高于NLN组 ( 18 9% ) ;APCR和IgG -ACA同时阳性LN的发生率 ( 7/ 7)明显高于APCR阳性而IgG -ACA阴性者( 12 / 2 4)。结论 :APCR和ACA在LN有较高的发生率 ,ACA引起的获得性APCR可能是LN的发病机制之一。 Objective:To explore the relationship between activated protein C(APCR),antiphospholipid antibodies and lupus nephritis(LN) and the possible reasons for APCR.Methods:APCR,ACA(lgG,lgM,lgA),LA,were measured with APTT±APC,ELISA,PTT-LA methods respectively in 33 LN patients and 37 SLE patients without LN(NLN).Results:The postive rates of APCR and ACA(IgG,IgM)in LN group were 57.6% and 42.4% respectively,which were significantly higher than that of NLN group(32.4% and 18.9% respectively).LN was more common in APCR and ACA-IgG positve patients(7/7) than in APCR positive but ACA-lgG negative patients (12/24).Conclusion:There were high prevalence of APCR and ACA in lupus nephritis.The acquired APCR induced by ACA may play an important role in LN's pathogenic mechanisms.
出处 《安徽医学》 2001年第4期1-3,共3页 Anhui Medical Journal
基金 安徽省自然科学基金资助 (98452 2 34)
关键词 狼疮性肾炎 抗活化蛋白C 抗磷脂抗体 APCR LN 发病机制 Lupus nephritis Activated protein C resistance Antiphospholipid antibody
  • 相关文献

参考文献10

  • 1Dahlback B, Carlsson M,Svensson PJ,et al. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant to activated protein C: predication of a cofactor to APC. Proc Natl Acad Sci USA, 1993;90:1004~1008
  • 2Tan EM,Cohen AS,Fries JF,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982; 25:1271 ~ 1277
  • 3Hughson MD, Nadsdy T. Renal thrombotic microangiopathy in patients with systemic lupus erythernatosus and the antiphospholipid syndrome. Am J Kidney Dis, 1992;20:150
  • 4Perdiguero M, Boronat M, Marco P, et al. The role of antiphospholipid antibodies in lupus nephropathy. Nephron,1995;71(1) :35~39
  • 5Bhandari S, Harnden P, Brownjohn AM, et al. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM, 1998; 91 (6): 401~ 409
  • 6Bertina RM, Koeleman PBC, Koster T, et al. Mutation in blood coagulation factor v associated with resistance to activated protein C. Nature, 1994; 369: 64~ 67
  • 7Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet, 1995; 346:1133- 1134
  • 8Eric HS, Lucy AS, Arthur RT, et al. Heredity resistance to APC:an uncommon risk factor for thromboembolic disease in lupus patients with antiphospholipid antibodies. Arthritis Rheum, 1997;40(9): 1720~ 1721
  • 9Justo A, Villa P, Espana F, et al. APC resistance phenotype in patients with antiphospholipid antibodies. J Lab Clin Med,1997; 130: 202~ 208
  • 10Carreras LO, Forastiero RR. Pathogenic role of antiproteinpospholipid antibodies. Haemostasis, 1996; 26 (suppl): 340 ~357

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部